• Profile
Close

Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin–piperaquine for malaria during pregnancy: An analysis using efficacy results from Uganda and Kenya, and pooled data

The Lancet Global Health Nov 23, 2020

Fernandes S, Were V, Gutman J, et al. - For prevention of malarial infection during pregnancy in HIV-negative women, long-lasting insecticidal nets together with intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine (IPTp-SP) are currently relied upon. In view of the increasing sulfadoxine–pyrimethamine resistance in Africa, researchers here examined the cost-effectiveness of intermittent preventive treatment in pregnancy with dihydroartemisinin–piperaquine (IPTp-DP), which is a promising candidate, vs IPTp-SP to prevent clinical malaria infection (and its sequelae) during pregnancy. Cost-effectiveness analysis was performed employing meta-analysis and individual trial results from three clinical trials conducted in Kenya and Uganda. Findings support the cost-effectiveness of IPTp-DP among HIV-negative pregnant women with high uptake of long-lasting insecticidal nets in regions with high malaria transmission and high sulfadoxine–pyrimethamine resistance. A comprehensive overview of the current evidence on the cost-effectiveness of IPTp-DP was provided in this work.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay